Beyond the Basics: Navigating the HIV-Cancer Intersection

This webinar will shed light on the reasons behind increased risk of certain cancers among people living with HIV and why their cancer outcomes are worse compared to people without HIV. The faculty will delve into evidence-based strategies to improve survival in HIV-associated cancers. The webinar also will cover potential treatment options that may exploit unique characteristics of these cancers to improve outcomes.

This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.

Target Audience

This activity is intended for Clinicians, Community Health Workers, and Direct Service providers.

Faculty

Dr. Kathryn Lurain MD, MPH-Associate Research Physician, National Cancer Institute, National Institute of Health
Dr. Lurain is a hematologist-oncologist and an expert in the treatment of virus-associated cancers and lymphoproliferative disorders. ShDr. e is the Clinical Director of the HIV and AIDS Malignancy Branch and an associate research physician at the National Cancer Institute. She earned her B.A. in Biology from Oberlin College and Masters in Global Public Health from George Washington University. She received her M.D. from the University of Virginia and completed Internal Medicine residency at the University of Chicago before completing fellowship in hematology and oncology at the National Cancer Institute. Her clinical research is focused on the development of new treatments for HIV-associated lymphomas using immunotherapy approaches. Her translational work focuses on understanding the changes in cellular and humoral immune function at the onset of virus-associated cancers and how immune function is affected by treatment. Dr. Lurain is an advocate for people living with HIV and their inclusion in clinical trials, and she is trained in the clinical care of sexual and gender minorities.

Learning Objectives

After completing this activity, the participant should be better able to:

• Identify the types of cancers that occur with higher frequency and the reasons for this increased incidence among people living with HIV.
• Explain reasons for the increased mortality among people living with HIV and cancer compared to the general population.
• Describe strategies that can be used to improve survival in people living with HIV and cancer.